Promatix Biosciences
PrivateLast Round
Series A
Apr 6, 2026
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Promatix Biosciences is a biotechnology company that develops next-generation bispecific antibody-drug conjugates for the treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Promatix Biosciences Comparables
Compare Promatix Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Synthetic Design Lab | 86% | |
| Neok Bio | 81% | |
| Adcentrx Therapeutics | 81% | |
Promatix Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 6, 2026 | ||||
| Seed | Mar 8, 2021 |
Promatix Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ALSA Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 6, 2026
Completed a Series A funding round.
- Jan 8, 2026
Grew 30% QoQ, from 10 to 13 employees.
Promatix Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Promatix Biosciences's valuation, stock price, and market status.